Indian biopharma firm Biocon has announced the signing of partnership agreement with Bahiafarma and Bionovis for Pe...
Nipro Corporation, a global healthcare and medical technology company, has announced the establishment of its Asia Pacif...
South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced that...
Viral Vector Manufacturing Facility (VVMF), Australia’s first viral vector Contract Development and Manufacturing ...
Novo Holdings, a leading global healthcare and life sciences investor, has announced a strategic minority investment in ...
BioSpectrum Asia has published The CEO Handbook 2026, a seventy two page Career Spotlight edition profiling fifty chief ...
Korea Advanced Institute of Science and Technology (KAIST) has partnered with Thermo Fisher Scientific to establish SHAR...
Japan-based Hodogaya Chemical has established a subsidiary to promote the nucleic acid therapeutics CDMO business. In it...
Japan-based Shionogi has received marketing authorisation from the Therapeutic Goods Administration (TGA) in Australia f...
South Korea-based Classys, a global player in medical aesthetics, has stepped into India, through its partnership with P...
Taiwan-based Horien Biochemical Technology has announced a major double milestone in its global expansion strategy, i.e....
US-based Thermo Fisher Scientific has announced the launch of the Thermo Scientific Multiskan Ease Absorbance Microplate...
Every planning season produces the same quiet moment. The forecasts are built, the templates have gone around twice, and...
Isotope analysis is moving beyond specialised laboratories towards broader, molecular-level applications. In this BioSpe...
ENA Respiratory, a clinical-stage pharmaceutical startup developing host defence enhancers for the prevention of complic...
Japan-based Ono Pharmaceutical has entered into a drug discovery partnership agreement with US-based Aitia, Inc. Under t...
Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and ...
South Korea-based Samsung Bioepis has announced the marketing approval of Ustekinumab BS Intravenous Infusion 130mg...
South Korea based Alteogen Inc. has entered into an option and license agreement with Novartis for the development and c...
Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a...
Thailand LAB INTERNATIONAL 2026 kicks off today at the Bangkok International Trade & Exhibition Centre (BITEC), brin...
EVENT WRAP-UP | ASIA BIO PARTNERING FORUM 2026 A forum that met the moment Some conferences describe the industry. The...
"Almost every company preparing for a partnering conversation prepares for the wrong gate. The rejection usually happens...
Cross-border partnership is usually discussed as two parties meeting in the middle. The more accurate picture is a struc...
Medtronic, a global leader in healthcare technology, has announced a strategic partnership with Hong Kong based startup ...
